Analysis of efficacy and safety of Ab Externo XEN gel stent implantation in the treatment of glaucoma
- Conditions
- Glaucoma
- Registration Number
- ChiCTR2400088780
- Lead Sponsor
- Hangzhou Branch of Eye and Optometry Hospital, Affiliated with Wenzhou Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1)Patients diagnosed with primary open-angle glaucoma (POAG), primary angle-closure glaucoma (PACG), or secondary glaucoma (SG) at the Hangzhou Branch of Eye and Optometry Hospital, Affiliated with Wenzhou Medical University;(2)Patients voluntarily opting for ab externo XEN gel stent implantation surgery, and having no prior history of XEN gel stent implantation;(3)Patients undergoing regular follow-up visits postoperatively, with the last follow-up occurring at least 1 year after the surgery.
(1)Patients with active ocular diseases (such as keratitis, retinal disorders, etc.) within one month before surgery;(2)Preoperative assessment indicating anterior chamber depth <2mm;(3)History of allergy to glutaraldehyde or porcine derivatives;(4)Patients who are pregnant or breastfeeding;(5) Patients with severe physical or mental health issues, such as end-stage heart disease, kidney disease, pulmonary disease, or advanced tumors;(6) Non-compliance with signing the informed consent form for the study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure;Number of IOP-lowering drugs;Surgical success rate;Surgical-related complications;
- Secondary Outcome Measures
Name Time Method Vision;Anterior chamber depth;Filtering bleb morphology;XEN gel stent status;